Which of the following are appropriate interventions to prevent constipation in pregnancy? Select all that apply.

Endocrine changes in pregnancyare crucial for maternal adaptation and fetal development. The placentaacts as a temporary endocrine organ producing hCG, hPL, progesterone, and estrogens. The pituitary glandenlarges due to lactotroph hyperplasia, increasing prolactin. The thyroid glandincreases hormone output with total T4 and T3 rising, though free T4 remains within 0.8–1.8 ng/dL. Adrenal glandsproduce more cortisol and aldosterone, elevating total plasma cortisol to 16–29 µg/dL. The pancreasincreases insulin secretion, but maternal tissues develop insulin resistance from hPL, predisposing to gestational diabetes.

Rationale for correct answers

1.The placenta functions as an endocrine organ, producing hCG to maintain the corpus luteum, progesterone to support gestation, estrogens for uterine growth, and hPL to induce insulin resistance.

2.The pituitary gland enlarges by about 30% in pregnancy, driven by lactotroph proliferation, which increases prolactin secretion to prepare for lactation.

4.The adrenal glands increase secretion of cortisol, corticosterone, and aldosterone. Cortisol rises progressively, reaching up to 2–3 times non-pregnant levels, modulating immune tolerance and metabolism.

5.The pancreas increases β-cell mass and insulin secretion. Peripheral insulin resistance develops from placental hormones, particularly hPL, which ensures glucose availability to the fetus.

Rationale for incorrect answers

3.The thyroid gland Enlarges slightly and increases production of thyroxine (T4)and triiodothyronine (T3). This maintains metabolic support for pregnancy.

Take home points

• The placenta is a temporary endocrine organ producing hCG, hPL, progesterone, and estrogens.

• The pituitary enlarges and prolactin secretion rises for lactation.

• The thyroid and adrenal glands increase hormone output to meet maternal-fetal demands.

• The pancreas adapts with increased insulin secretion but maternal insulin resistance develops.

Hypercoagulability in pregnancydevelops as a protective adaptation to minimize hemorrhageat delivery, but it also increases the risk of thromboembolism. There is a marked rise in fibrinogenand several clotting factors(VII, VIII, IX, X, XII), while fibrinolytic activity decreases. Normal fibrinogen levels in nonpregnant women are 200–400 mg/dL, but in pregnancy, they rise to 400–650 mg/dL. This procoagulant state peaks in the third trimester and the puerperium.

Rationale for correct answer

2.Increased fibrinogen levels contribute to the hypercoagulable state of pregnancy. Elevated fibrinogen enhances clot formation and is a major factor in increasing the risk of venous thromboembolism, which is one of the leading causes of maternal morbidity and mortality.

Rationale for incorrect answers

1.Decreased clotting factors would reduce coagulation and increase the risk of bleeding, not thrombosis. Pregnancy is characterized by increased clotting factor activity, not reduction.

3.Reduced platelet count (gestational thrombocytopenia) can occur, but it is usually mild and not enough to outweigh the hypercoagulable changes. A lower platelet count actually tends toward bleeding risk, not thromboembolism.

4.Decreased white blood cell count is not typical in pregnancy. Instead, leukocytosis (WBC up to 12,000–15,000/µL, sometimes 25,000/µL in labor) is common. White blood cell levels are not directly related to thromboembolic risk in pregnancy.

Take home points

• Pregnancy is a hypercoagulable state due to increased fibrinogen and clotting factors.

• Elevated fibrinogen levels (400–650 mg/dL) significantly increase thromboembolism risk.

• Platelet count may slightly fall, but this does not negate the hypercoagulable effect.

• Thromboembolism is a major cause of maternal morbidity and mortality, especially postpartum.